Tobramycin Solution Shortage

Last Updated: June 16, 2025
Status: Discontinued

To Be Discontinued:

• Tobramycin, Solution, 300 mg/4 mL (Teva Pharmaceuticals USA, Inc.)
• Tobramycin, Solution, 300 mg/5 mL (Teva Pharmaceuticals USA, Inc.)

Tobramycin, Solution, 300 mg/4 mL (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0093-3750-28
Status: To Be Discontinued
Date of update: June 16, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Pulmonary/Allergy
Date discontinued: June 16, 2025
Initial posting date: June 16, 2025
Contact info: 800-545-8800

Tobramycin, Solution, 300 mg/4 mL (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0093-3750-63
Status: To Be Discontinued
Date of update: June 16, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Pulmonary/Allergy
Date discontinued: June 16, 2025
Initial posting date: June 16, 2025
Contact info: 800-545-8800

Tobramycin, Solution, 300 mg/5 mL (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0093-4085-63
Status: To Be Discontinued
Date of update: June 16, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Pulmonary/Allergy
Date discontinued: June 16, 2025
Initial posting date: June 16, 2025
Contact info: 800-545-8800

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer